BrightInsight

Overview
Activities
News
Telehealth?
Product stageSegments
Growth
?
Technology Service Providers
?

BrightInsight is a spin-off of electronic contract manufacturer Flex. The startup operates a regulatory-compliant cloud platform with which biopharma and MedTech companies can develop digital healthcare apps, such as software as a medical device, digital therapeutics, connected medical device apps, and apps for rare disease support and chronic disease management.

As of January 2022, the company had 20 biopharma customers including Roche, Sanofi, AstraZeneca, CSL Behring, and novo nordisk.

Key customers and partnerships

In September 2022, the company brought on Woebot Health, Xealth, and Clarita Rx to expand its network of healthcare providers and technology companies. The network, called the ‘BrightInsight Ecosystem,’ was launched earlier in the month to drive digital innovation, technology adoption, and customer engagement in the healthcare industry. The BrightInsight Ecosystem currently includes 20 providers of healthcare and technology solutions, including Google Cloud, Lyniate, and Roche. The ecosystem also includes four venture capital firms; Eclipse, General Catalyst, Insight Partners, and New Leaf Venture Partners.

Additionally, in September 2022, the company announced it had joined the health assurance network of General Catalyst. The venture capital firm’s network focuses on encouraging collaboration between healthcare providers and technology companies. General Catalyst believes BrightInsight can help other entities within the network achieve scale and customer adoption of their respective solutions.


In January 2023, the company partnered with ixlayer, a health testing solutions provider, to add the company to its BrightInsight ecosystem. Through this partnership, drug companion apps can be developed which would incorporate ixlayer’s diagnostic testing and BrightInsight’s “Disease Management Solution.”

Most recently, in May 2024, BrightInsight expanded its partnership with Google Cloud to incorporate AI technology into its Disease Management Solution to improve patient care and healthcare provider efficiency. By integrating Google Cloud's GenAI models into BrightInsight's solutions, patients were able to access information through an AI-powered chatbot, while healthcare providers could quickly identify issues with medication or treatments. Additionally, BrightInsight planned to gear up its internal operations by using this technology to troubleshoot issues and generate in-depth data analytics.

HQ location:
6201 America Center Drive Sunnyvale CA USA
Founded year:
2017
Employees:
101-250
IPO status:
Private
Total funding:
USD 166.0 mn
Last Funding:
USD 101.0 mn (Series C; Mar 2021)
Last valuation:
USD 750.0 mn (Mar 2021)
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.